Platinum Level Sponsors
Ever since we introduced the first commercial insulin in 1923, Lilly Diabetes has been a global leader in diabetes care. Today, Lilly continues to develop innovative products, programs, and resources to help people with type 1 diabetes. For the past twelve years, Lilly has been a proud platinum sponsor of the Friends for LifeÂ® Orlando conference.
Join us at our booth to see all the ways we support the type 1 community and how your family can get involved. You can learn more about the role we play in diabetes camps and scholarships for everyday heroes with type 1, discover awards that acknowledge success in diabetes management, and be inspired by the achievements of NASCAR driver Ryan Reed in managing his type 1 diabetes. Youâ€™ll also be able to check out our popular books for families managing type 1 diabetes. They've been created in collaboration with Disney and explore real-life issues that affect families just like yours. Be sure to pick up your free copy of each of the Lilly Diabetes and Disney storybooks, featuring Coco the monkey.
In 1923, the founders of Novo Nordisk began a journey to change diabetes. Today, we are thousands of employees across the world with the passion, the skills and the commitment to continue this journey to prevent, treat and ultimately cure diabetes. Novo Nordisk is proud to once again be a Platinum Level Sponsor of the Friends for Life® conference, supporting the Family and Friends Banquet and Sports Central. Please come see us at the exhibition to learn more about our type 1 support program, our new camp program and be among the first to learn about the first and only durable insulin pen with 0.5 unit doing and memory function - NovoPen Echo®. To learn more about Novo Nordisk and our support to the Type 1 diabetes community visit us at www.novonordisk-us.com.
Gold Level Sponsors
BD is a leading medical technology company that benefits countless lives worldwide. We advance health by improving the ways that discovery, diagnostics and delivery of care are conducted. With 45,000 employees at work in more than 50 countries, we work in close collaboration with customers and partners to develop innovative products and solutions that enhance outcomes, better manage healthcare delivery costs, increase efficiencies, improve healthcare safety, and expand access to health. Because weâ€™ve been doing this for over 100 years, our portfolio, leadership and partnerships make a difference for global healthcare.
Dexcom, Inc., headquartered in San Diego, California, is dedicated to helping people better manage their diabetes by providing exceptional continuous glucose monitoring (CGM) products and tools for adult and pediatric patients. Our latest-generation CGM, the Dexcom G5â„˘ Mobile CGM System, is the first FDA-approved, fully mobile System for both adults and children 2 years and older. Patients can not only view their real-time glucose data via their smart device*, but also share it with loved ones without needing a receiver. Our CGM features customizable alerts and alarms to warn patients of highs and lows and how quickly they may be happening. We also offer Dexcom CLARITYâ„˘, an advanced reporting tool for users to identify their unique glucose patterns, while also discovering potential solutions to help them spend more time in their target range. For more information, visit www.dexcom.com.
*For a list of compatible devices, please visit www.dexcom.com/compatibility
Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. Insulet's OmnipodÂ® Insulin Management System is a revolutionary insulin infusion system â€“ the first and only tubeless system in the US â€“ that gives kids the freedom to be kids, and parents the peace of mind of continuous insulin therapy. The OmnipodÂ® system packs all the functionality of today's "smart" insulin pumps in two discreet, easy-to-use wireless parts, featuring an integrated FreeStyleÂ® blood glucose meter, and, best of all, no cumbersome tubing. The remote Personal Diabetes Manager (PDM) allows parents and caregivers additional control, and with Omnipodâ€™sÂ® convenient auto-cannula insertion, your child never has to see or handle a needle. To learn more and hear from real OmnipodÂ® users, please visit www.MyOmniPod.com. Insulet is, once again, delighted to support Friends for LifeÂ® Orlando as a Gold Level Sponsor.
Tandem Diabetes Care, Inc. is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures the t:slim X2â„˘ Insulin Pump, the next-generation color touchscreen pump, the t:flexÂ® Insulin Pump and the t:slim G4â„˘ Insulin Pump, the first CGM-enabled pump with touch-screen simplicity.
Silver Level Sponsors
The Leona M. and Harry B. Helmsley Charitable Trust aspires to improve lives by supporting exceptional nonprofits and other mission-aligned organizations in health, selected place-based initiatives, and education and human services. Since 2008, when the Trust began its active grantmaking, it has committed more than $1 billion. The Helmsley Type 1 Diabetes Program is the largest private foundation funder of T1D-related research, treatment and support services.
Bronze Level Sponsors
With a shared vision of creating a world without limits for people with diabetes, the Johnson & Johnson Diabetes Care Companies are a collaboration of Johnson & Johnson companies dedicated to diabetes and includes LifeScan, Inc., a world leader in blood glucose monitoring; Animas Corporation, maker of innovative insulin delivery systems; Calibra Medical, Inc. developer of OneTouch Viaâ„˘ on-demand insulin delivery; and the Johnson & Johnson Diabetes Institute, LLC, a global initiative to improve care and better outcomes worldwide through education and training programs. At Animas, weâ€™re committed to addressing key unmet needs of patients with diabetes across the continuum of care, and are steadfast in our pursuit of meaningful innovation. The AnimasÂ® VibeÂ® Insulin Pump & CGM System is our most advanced insulin pump to date, and is the only integrated pump and continuous glucose monitoring (CGM) system approved for children as young as 2 years of age. Animas is pleased to be a Bronze Sponsors of Friends for Life® Orlando 2017. To learn more about Animas, the AnimasÂ® VibeÂ® System or the OneTouch PingÂ® Glucose Management System, please visit www.Animas.com.
Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping improve the lives of people with diabetes by empowering them to take charge of their health. We use our innovation and specialist expertise in diabetes to develop high quality solutions and tools that make a simple, positive, daily difference for people with diabetes. Home to the world renowned CONTOURâ„˘ portfolio of blood glucose monitoring systems, our products combine advanced technology with user-friendly functionality that help people with diabetes to manage their condition. We are committed to continued research, innovation and development of new products. As a leader in diabetes care and a trusted partner, we collaborate closely with healthcare professionals and other partners to ensure our products meet the highest standards of accuracy and compliance. Ascensia Diabetes Care was established in 2016 through the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings Co., Ltd. Ascensia Diabetes Care products are sold in more than 125 countries. Following the close of the transaction in all countries, Ascensia Diabetes Care will have around 1,400 employees and operations in 38 countries. For further information please visit the Ascensia Diabetes Care website at www.ascensia.com. CONTOURâ„˘ is a registered trademark of Ascensia Diabetes Care Holdings AG.
Abbott Diabetes Care, a division of global health care company Abbott, is committed to improving the lives of people with diabetes. The company manufactures, distributes and markets innovative glucose monitoring systems and offers valuable services to help patients and healthcare professionals better manage diabetes care needs. Abbott Diabetes Care is pleased to be a sponsor of the 2017 Friends for Life® Orlando conference. For more information, visit www.abbottdiabetescare.com.
As a member of the Janssen Pharmaceutical Companies of Johnson & Johnson, Janssen Pharmaceuticals, Inc. is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Driven by our commitment to patients, we develop innovative products, services and healthcare solutions to help people throughout the world. Please visit www.Janssen.com for more information.
Sanofi strives to help people manage the complex challenge of diabetes by delivering innovative, integrated and personalized solutions. Driven by valuable insights that come from listening to and engaging with people living with diabetes, the Company is forming partnerships to offer diagnostics, therapies, services, and devices. Sanofi markets medications for people with type 1 or type 2 diabetes. To follow conversations about life, and life with diabetes connect with us and register for diabetes related articles and lifestyle tips on The DX, like us on Facebook at Sanofi US Diabetes and follow us on Twitter at @diabetes_sanofi.
Friends of CWD
The American Diabetes Association (Association) is the global authority on diabetes and since 1940 has been committed to its mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. To tackle this global public health crisis, the Association drives discovery in research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and provides support and advocacy for people living with diabetes, those at risk of developing diabetes and the health care professionals who serve them. For children with diabetes, the Association serves families as they confront school discrimination issues through our Safe at School initiative. The Association is also the largest single provider of camps for children with diabetes with more than 75 sessions of day and residential camps throughout the nation. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn).
Beta Bionics, Inc., is a Massachusetts public benefit corporation committed to innovating, developing, commercializing, and disseminating the iLetÂ®, a dual-hormone bionic pancreas for people living with T1D. Our stated benefit mission is (1) to provide a turnkey solution for safe and effective autonomous glycemic control, (2) to bring this technology to as many people with T1D as possible, (3) to continue to innovate and to offer the latest advances, and (4) to act in the best possible interest of the T1D community. As a benefit corporation founded by parents of children with T1D, Beta Bionics, unlike any other medical technology company, is protected under Massachusetts law to prioritize its benefit mission and place the best interests of the T1D community ahead of all other considerations. Beta Bionics is pleased to be a sponsor of Friends for LifeÂ®. To learn more about Beta Bionics, the iLet, and our public benefit mission, visit us at www.betabionics.org and @BetaBionics on social media.
Founded in February 2015, Beyond Type 1 creates and funds a portfolio of programs, technologies and innovations that those living with Type 1 diabetes need to manage, live and thrive. Our goal is to highlight the brilliance of those fighting this disease every day while always working toward ensuring a cure is on its way. By establishing a supportive community via powerful social media, people are connected on a global scale in a new way. Our Instagram campaign "Living Beyond," showcases the age, range and variance of those living their best life with T1D, and our website and social media platforms provide education and support. High profile collaborations and carefully curated special events will provide education and awareness, affording a greater capacity for strategic fundraising. Because our Founders + Founding Friends pay all operational and fundraising expenses, 100% of every dollar raised directly supports the most promising global efforts and programs working to educate, advocate and cure type 1 diabetes. We aim to be provocative, inclusive and disruptive: putting a face on this disease, clearing up misunderstandings about who is affected by T1D and eradicating the stigma that comes from living with a chronic disease. We recognize there is a different narrative to be told: that of a strong empowered community living a powerful life beyond the diagnosis. We also recognize a future free of T1D is possible and we are here to make certain that future materializes. We are here to disrupt diabetes.
One of the first sponsors of Children With Diabetes in their very first year, the Diabetes Research Institute and Foundation are proud to be a part of this important educational and fun event for those affected by diabetes. The mission of the Diabetes Research Institute Foundation is to provide the Diabetes Research Institute with the funding necessary to cure diabetes now. The Diabetes Research Institute, a Center of Excellence at the University of Miami Miller School of Medicine, leads the world in cure-focused research. As the largest and most comprehensive research center dedicated to curing diabetes, the DRI is aggressively working to develop a biological cure by restoring natural insulin production. Researchers have already shown that diabetes can be reversed through islet transplantation, with some study patients living insulin free for more than a decade. The Institute is now building upon these promising outcomes by developing a DRI BioHub, an integrated â€śmini organâ€ť that mimics that native pancreas, containing thousands of insulin-producing cells that sense blood sugar levels and produce the precise amount of insulin needed in real time. The Diabetes Research Institute and Foundation were created for one reason â€“ to cure diabetes â€“ which is and will continue to be its singular focus until that goal is reached. For the millions of children and adults affected by diabetes, the Diabetes Research Institute is the best hope for a cure. For more information, please visit www.DiabetesResearch.org or call 800-321-3437.
JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal. In addition to our research funding and leadership, JDRF's outreach efforts provide practical support and resources for people with T1D and their families every step of the way as they live with T1D. JDRF is proud to partner with Children with Diabetes by sponsoring regional and national conferences as a charity partner, and supporting sessions at Friends for Life®. For more information, visit the JDRF website at www.jdrf.org, or call 800-533-CURE.
Mallinckrodt is a global specialty pharmaceutical company dedicated to its mission: Managing Complexity. Improving Lives. Our Acquire to Invest business model is applied to therapies that aid healthcare providers in treating patients, including for small, underserved populations who may be challenged by devastating conditions. We invest in areas such as autoimmune and rare diseases; immunotherapy and neonatal respiratory critical care therapies; analgesics and hemostasis products. Our investment in these medicines--both in development and after approval--provides clinical and economic data to help clinicians as they make treatment choices, and in some instances is introducing long approved medications to a whole new generation of physicians and, ultimately, patients. Learn more at www.mallinckrodt.com.
ThromboGenics is a biopharmaceutical company focused on developing innovative treatments for diabetic eye disease. The companyâ€™s attractive pipeline of disease modifying drug candidates is targeting the key segments of the diabetic eye disease market. ThromboGenics is conducting the CIRCLE study, a Phase II clinical trial to assess THR-409 (ocriplasmin) as a potential treatment to prevent the patients with non-proliferative diabetic retinopathy progress to proliferative diabetic retinopathy. THR-317, a PIGF inhibitor being developed to treat diabetic macular edema, or as a combination therapy with anti-VEGF treatments, is expected to enter the clinic by year end 2016. In addition, THR-149, a plasma kallikrein inhibitor, which has resulted from research collaboration with Bicycle Therapeutics, and THR-687, an integrin antagonist, which was in-licensed from Galapagos, are in late stage pre-clinical development.
Top-notch programming, strong local newscast, and the station's innovative promotional initiatives makes Telemundo Orlando the #1 Spanish-language station in the market. Orlando is now the No. 3 Hispanic TV market on the East Coast after New York City and Miami. Telemundo Orlando health initiative, Salud, Belleza y Bienestar (Health, Beauty and Wellness), provides information and resources to empower and improve the physical and mental well-being of the Hispanic community.
[ Report Intro | Sunday through Tuesday | Wednesday | Thursday | Friday | Saturday | Sunday
Photos | Docu-Diabetes III | Other Write Ups | Presentations | Sponsors | Print Program | Event Announcement ]
|Return to the Top of This Page|
Last Updated: Monday July 31, 2017 14:15:12
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.